World Scientific
Skip main navigation

Cookies Notification

We use cookies on this site to enhance your user experience. By continuing to browse the site, you consent to the use of our cookies. Learn More
×

System Upgrade on Tue, May 28th, 2024 at 2am (EDT)

Existing users will be able to log into the site and access content. However, E-commerce and registration of new users may not be available for up to 12 hours.
For online purchase, please visit us again. Contact us at customercare@wspc.com for any enquiries.
No Access

Future Strategies for the Development of Antiplatelet Drugs

    https://doi.org/10.1142/9781860948527_0007Cited by:0 (Source: Crossref)
    Previous
    Next
    Abstract:

    The following sections are included:

    • Introduction

    • Arterial Thrombosis, Platelets, Cardiovascular Disease, and Antiplatelet Therapies

    • Drug Development

    • Antiplatelet Drug Development

      • Acute versus chronic usage and advantages/limitations of IV versus oral preparations

      • General issues to consider in antiplatelet drug development

      • Developing antiplatelet therapies for use in patients with NSTE ACS and during PCI

      • Developing antiplatelet therapies for use in patients with STEMI

      • Developing antiplatelet therapies for use in patients with chronic coronary artery disease

    • Future Directions

    • References